Johnson & Johnson stock after-hours at EUR 226.28: minus 0.54 percent versus prior close
Published on 10/05/2026 at 17:48 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Johnson & Johnson stock was at EUR 226.28 after-hours at 5:45 p.m. CEST on October 5, 2026, down minus 0.54 percent versus the prior close of EUR 227.50 at Lang & Schwarz.
Trading after the Xetra close
Lang & Schwarz showed a bid of EUR 226.25 and an ask of EUR 226.30 at 5:45 p.m. CEST. The further course of after-hours trading at Lang & Schwarz until 11:00 p.m. CEST is shown by the continuously updated real-time quote of Johnson & Johnson stock.
ICOTYDE data reported
On October 2, 2026, Johnson & Johnson announced two-year data from the Phase 3 ICONIC-TOTAL study of ICOTYDE (icotrokinra) in adults and adolescents with moderate-to-severe plaque psoriasis affecting high-impact sites, according to a PR Newswire release. Through Week 112, 70% of treated patients achieved clear or almost clear skin under the stated Investigator’s Global Assessment measure. Site-specific complete clearance reached 60% for scalp psoriasis, 89% for genital psoriasis and 63% for hand and foot psoriasis.
Survey on menopause and eye health
In a separate October 1, 2026 release, Johnson & Johnson said a global survey of 6,000 women found that 40% connected eye changes with the menopause transition. The company said 66% had experienced dry, gritty or irritated eyes and 60% blurred vision. Ipsos conducted the survey for Johnson & Johnson across six countries, according to the company’s release.
